On October 9, 2020, we will provide cMylc cells for the novel coronavirus research. cMylc cells, derived from iPS cells (Mylc) that we developed in-house, are the host cells of novel coronavirus as the first human blood cells. The viral infection and proliferation effects are comparable to those of Vero cells(Monkey kidney derived).
On September 9, 2020, we will release the Mylc ELISA (Human IL-6) Kit, a kit for the evaluation of cytokines for the safety of functional materials related to food and cosmetics, etc., using myeloid cells derived from iPS cells (Mylc) that we developed in-house.
MiCAN, as a sponsor, will participate in the Joint international tropical medicine meeting (JITMM: usually held in Bangkok, Thailand) to be held on December 15-16, 2020. In the sponsorship session, we will have presentations on the latest research results on novel coronavirus infections using our immature dendritic cells (Mylc) and other products.